Summary:
Click image to enlargeA phase 3 clinical research study is being conducted for moderate to severe eczema. An investigational drug or placebo will be given to qualified participants to evaluate the safety and effectiveness of an investigational drug in the treatment of moderate to severe eczema.
Qualified Participants Must:
• Be at least 18 years old
•
Have had chronic atopic dermatitis for at least 2 years
•
Have documented inadequate response to topical medications for treatment of Atopic Dermatitis
Qualified Participants May Receive:
Participants will receive all study-related care and study drug at no cost. Reimbursement for time and travel related to study may be available as well.